Profile data is unavailable for this security.
About the company
Selcuk Ecza Deposu Ticaret ve Sanayi AS (Selcuk Ecza) is a Turkey-based medical warehousing company that serves as the distribution channel between pharmaceutical companies, pharmacies and hospitals. The Company distributes pharmaceutical products, as well as cosmetics, personal care, infant food, vitamins, medical and similar products. The Company operates through a network of five branches located in Ankara, Samsun, Izmir, Konya and Antalya. As of December 31, 2011, the Company’s subsidiaries included As Ecza Deposu Ticaret AS, which is engaged in operating as a pharmacy depot through four branches located in Ankara, Kayseri, Izmir and Konya, and Selcuk Ecza Deposu Dis Tic AS, which is active in the export and import of a range of drugs and patent medicines, medical supplies together with pharmacy depot operations.
- Revenue in TRY (TTM)97.72bn
- Net income in TRY223.21m
- Incorporated1970
- Employees6.03k
- LocationSelcuk Ecza Deposu Ticaret ve Sanayi ASAltunizade Mah. Kusbakisi Cad. No:37Altunizade NakkastepeISTANBUL 34662TurkeyTUR
- Phone+90 2 165540554
- Fax+90 2 165540556
- Websitehttps://selcukecza.com.tr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nu Skin Enterprises, Inc. | 63.97bn | 279.20m | 19.09bn | 3.70k | 72.94 | 0.7124 | 7.39 | 0.2984 | 0.1622 | 0.1622 | 38.97 | 16.61 | 1.09 | 1.95 | 32.75 | 532,197.60 | 0.4739 | 6.80 | 0.5848 | 8.90 | 68.93 | 73.45 | 0.4365 | 5.26 | 1.28 | -- | 0.3797 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
| YSB Inc | 76.15bn | -14.31bn | 21.53bn | 6.31k | -- | 2.50 | -- | 0.2827 | -25.64 | -25.64 | 47.50 | 3.24 | -- | -- | -- | 2,908,323.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
| Uniphar PLC | 88.83bn | 1.56bn | 24.41bn | 3.26k | 15.66 | 2.11 | 8.71 | 0.2748 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
| Herbalife Ltd | 164.85bn | 4.46bn | 28.14bn | 9.20k | 6.33 | -- | 3.44 | 0.1707 | 1.37 | 1.37 | 50.57 | -- | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.76 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
| NanJing Pharmaceutical Co Ltd | 240.41bn | 2.59bn | 28.57bn | 4.90k | 11.05 | 0.976 | -- | 0.1188 | 0.4397 | 0.4397 | 40.75 | 4.98 | 1.78 | 8.70 | 4.11 | 10,929,970.00 | 2.37 | 2.32 | 8.06 | 8.94 | 5.98 | 6.41 | 1.33 | 1.30 | 1.09 | 2.91 | 0.6148 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Neuca SA | 95.10bn | 1.18bn | 32.45bn | 5.19k | 28.13 | 4.06 | 14.71 | 0.3412 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 97.72bn | 223.21m | 32.73bn | 6.03k | 146.62 | 2.17 | 51.09 | 0.3349 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
| DocMorris AG | 34.40bn | -4.17bn | 39.88bn | 1.45k | -- | 2.24 | -- | 1.16 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
| Guangxi LiuYao Group Co Ltd | 95.34bn | 3.99bn | 40.80bn | 5.58k | 9.27 | 1.19 | -- | 0.4279 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| Sigma Healthcare Ltd | 72.41bn | 95.55m | 43.40bn | 156.00 | 317.72 | 2.26 | 60.89 | 0.5993 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
Data as of May 02 2024. Currency figures normalised to Selcuk Ecza Deposu Ticaret ve Sanayi AS's reporting currency: Turkish Lira TRY
2.18%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 4.02m | 0.65% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.00m | 0.48% |
| MFS International Singapore Pte. Ltd.as of 31 Mar 2024 | 2.61m | 0.42% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 1.47m | 0.24% |
| MFS International (UK) Ltd.as of 31 Mar 2024 | 959.29k | 0.15% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 362.45k | 0.06% |
| Massachusetts Financial Services Co.as of 31 Mar 2024 | 301.11k | 0.05% |
| State Street Global Advisors Ltd.as of 04 Apr 2024 | 282.08k | 0.05% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 279.67k | 0.05% |
| Parametric Portfolio Associates LLCas of 29 Feb 2024 | 240.30k | 0.04% |
More ▼
Data from 31 Dec 2023 - 25 Apr 2024Source: FactSet Research Systems Inc.
